Abstract
OBJECTIVE: Transient hypothyroxinemia in premature newborns has been linked with poor neonatal outcomes. We designed this study to evaluate the effects of early thyroxine (T4) administration in the premature infant.
STUDY DESIGN: A total of 49 newborns less than 32 weeks' gestation, were randomized in a double-blind, placebo-controlled trial. Within the first 48 hours of life, T4 (10 or 20 μg/kg; intravenous or through nasogastric tube, respectively) was administered for a total of 21 days. Chronic lung disease, the primary outcome variable, was defined by oxygen dependency at 28 days of life.
RESULTS: The incidence of chronic lung disease, death, grade III or IV intraventicular hemorrhage, periventicular leukomalacia, and sepsis was not different in the placebo and treated groups.
CONCLUSION: Early T4 supplementation in preterm newborns less than 32 weeks' gestation does not decrease the incidence of chronic lung disease or other complications of prematurity.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Author information
Authors and Affiliations
Additional information
This study was supported in part by grant # 3 M0I RR00425 from the National Institutes of Health, General Clinical Research Center Branch, a Clinical Associate Physician grant awarded to LMS, and a grant from Boots Pharmaceuticals.
Rights and permissions
About this article
Cite this article
Smith, L., Leake, R., Berman, N. et al. Postnatal Thyroxine Supplementation in Infants Less Than 32 Weeks' Gestation: Effects on Pulmonary Morbidity. J Perinatol 20, 427–431 (2000). https://doi.org/10.1038/sj.jp.7200417
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.jp.7200417
- Springer Nature America, Inc.
This article is cited by
-
Surviving sepsis campaign international guidelines for the management of septic shock and sepsis-associated organ dysfunction in children
Intensive Care Medicine (2020)
-
An explanatory randomised placebo controlled trial of levothyroxine supplementation for babies born <28 weeks’ gestation: results of the TIPIT trial
Trials (2013)
-
TIPIT: A randomised controlled trial of thyroxine in preterm infants under 28 weeks' gestation
Trials (2008)
-
Increasing illness severity in very low birth weight infants over a 9-year period
BMC Pediatrics (2006)
-
Incidence of Low Free T4 Values in Premature Infants as Determined by Direct Equilibrium Dialysis
Journal of Perinatology (2004)